Bringing Leading-Edge Leukemia Care to Southern California

City of Hope® is home to a world-class, multidisciplinary team of leukemia specialists with expertise in diagnosing and treating all types and subtypes of leukemia, from early-stage disease to rare and complex cases. A globally recognized leader in leukemia care and research, City of Hope Duarte has been named among the top “Best Hospitals” for cancer for nearly two decades by U.S. News & World Report, which has also repeated rated us as “high -performing” in the treatment of leukemia and other blood cancers.

At City of Hope, one of fewer than 60 National Cancer Institute-designated comprehensive cancer centers in the nation, our personalized approach to care is founded in offering innovative treatment options, comprehensive care and integrative support for patients and their loved ones. We offer patients in Southern California and beyond access to advanced tumor profiling, breakthrough immunotherapies — including chimeric antigen receptor (CAR) T cell and bispecific therapies), bone marrow and stem cell transplantation, and CAR T cell therapy for hematologic malignancies. We offer patients in Southern California and beyond access to advanced tumor profiling, breakthrough immunotherapies—including chimeric antigen receptor (CAR) T cell and bispecific therapies—as well as bone marrow and stem cell transplantation for hematologic malignancies. 

Our Approach to Care

Through our unique combination of world-renowned clinical expertise, breakthrough translational research and access to advanced medical technologies and techniques, City of Hope is able to offer patients outstanding continuity of care. Patients referred to City of Hope for leukemia treatment benefit from:

  • Multidisciplinary care delivered by world-renowned blood cancer experts — including hematologists, medical and radiation oncologists and supportive care staff — who are experienced in diagnosing and treating both adult and pediatric leukemias
  • Access to comprehensive, advanced molecular profiling and risk assessment tests that can help identify treatment options personalized to each patient’s unique diagnosis
  • Our pioneering approach to leukemia care, which combines breakthrough drug therapies, chemotherapy, radiation therapy, and bone marrow and stem cell transplantation
  • Specialized observation protocols for patients with slow-growing leukemia subtypes, which can help guide the timing of treatment so that it’s as effective as possible
  • Access to supportive care services that can help patients and loved ones manage the physical and emotional effects of cancer before, during and after treatment
  • City of Hope’s hematopoietic stem cell transplantation program, which is one of the largest and most successful in the country, having performed more than 20,000 bone marrow or stem cell transplants (BMT), one of the first programs in the country to reach such heights
  • Our leading-edge cellular immunotherapy program, which has treated to date treated more than 1,800 patients treated to date with immune effector cells, including CAR T cell therapy
  • The largest outpatient center for CAR T cell therapy, with approximately 90% of patients receiving CAR T cell therapies as outpatients, with the opportunity to receive treatment and stay at an on-campus hotel in Duarte, allowing them to be with loved ones while undergoing active treatment
  • Expert radiation oncologists trained in offering total marrow irradiation for leukemia, a precision radiotherapy that reduces radiation exposure to healthy tissues and organs
  • Access to the Gehr Family Center for Leukemia Research, which is home to a team of scientists and clinicians whose laboratory research focuses on furthering our understanding of the causes of leukemia and developing new disease-specific therapeutics to improve outcomes and quality of life
  • Our extensive clinical trials program, which has developed multiple innovative new therapeutics since its inception

Code Acute Leukemia™

Our unique Code Acute Leukemia™ program allows clinicians to expedite the transfer of patients showing symptoms of acute leukemia to our flagship hospital, City of Hope Duarte, for immediate care.

Collaborate With Us

The City of Hope leukemia team partners with referring physicians and clinical providers in Southern California and beyond to ensure that every patient referred to us receives comprehensive evaluation and begins active cancer treatment in a timely and compassionate manner.

Meet Our Leukemia Team

Guido Marcucci

Guido Marcucci, M.D.

  • Vice Chair, Department of Hematology
  • Chief, Division of Leukemia
  • Chair and Professor, Department of Hematologic Malignancies Translational Science
  • Director, Gehr Family Center for Leukemia Research
  • Professor, Department of Hematology & Hematopoietic Cell Transplantation
  • Director, Hematopoietic Tissue Biorepository (HTB)
Stephen Forman

Stephen Forman, M.D.

  • Director, Hematologic Malignancies Research Institute
  • Professor, Department of Hematology & Hematopoietic Cell Transplantation
  • Principal Investigator, Lymphoma SPORE
  • Director, T Cell Therapeutics Research Laboratories
  • Co-director, Hematologic Malignancies Program, Comprehensive Cancer Center
  • Professor, Department of Medical Oncology & Therapeutics Research
Sunmin Park

Sunmin Park, M.D., Ph.D.

Assistant Professor, Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation

Brian Ball

Brian Ball, M.D.

  • Assistant Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation
Salman Otoukesh

Salman Otoukesh, M.D.

  • Assistant Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation
  • Associate Program Director of Hematology/Oncology Fellowship (ACGME)
  • Co-Chair ClinicalPath CML, Adult Hematopoietic Cell Transplantation and Cellular Therapy, City of Hope, Duarte, California
  • Physician Leader for Duarte Ambulatory Leukemia Clinic (Triad Shared Leadership Model), Adult Hematopoietic Cell Transplantation and Cellular Therapy, City of Hope, Duarte, California
  • Director of Adult Post Allogeneic Stem Cell Transplantation Survivorship program, Adult Hematopoietic Cell Transplantation and Cellular Therapy, City of Hope, Duarte, California
Hoda Pourhassan

Hoda Pourhassan, M.D.

  • Assistant Professor, Department of Hematology & Hematopoietic Cell Transplantation
Pamela Becker

Pamela Becker, M.D., Ph.D.

  • Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation and Department of Hematologic Malignancies Translational Science
  • Director, Adult Commercial Gene Therapy
Monzr Al Malki

Monzr Al Malki, M.D.

  • Professor, Department of Hematology & Hematopoietic Cell Transplantation
  • Director, Unrelated Donor BMT Program
  • Director, Haploidentical Transplant Program
  • Medical Director, City of Hope Histocompatibility (HLA) & Immunogenetics Laboratory
Karamjeet Sandhu

Karamjeet Sandhu, M.D.

  • Assistant Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation
  • Program Director, HCT/Cellular Therapy Fellowship Program

To meet the entire team visit: Los Angeles-Area Leukemia Team | City of Hope

Refer a Patient

To refer a patient to City of Hope’s leukemia experts, call 800-826-HOPE (4673) or email us at [email protected].

Refer a Patient Today